SSlabIndex
Signal RoomGraded MarketMorning BriefTrack RecordPortfolioPricing
SSlabIndex™

Every card scored — raw and graded. Every opportunity tracked. Public results.

Newsletter

Best cards and slabs to invest in this week, every Monday.

Free. Mondays. Unsubscribe in one click.

Market
  • Signal Room
  • Graded Market
  • Morning Brief
  • Track Record
  • Best cards to grade
  • Newsletter
Account
  • Portfolio
  • Pricing
  • Log in
  • Create account
Company
  • About
  • vs PriceCharting
  • Terms
  • Privacy
  • Refunds

SlabIndex publishes market analysis, not investment advice. Nothing here is a recommendation to buy or sell, no outcome is guaranteed, and past results — including every figure in the track record — do not predict future ones. Collectibles are illiquid and can lose value. Trade with money you can afford to lose.

Home/Pokémon (Japanese)/Firebreather
Firebreather
Hover to enlarge
Raw (NM)
$1.10
-2.6% 30d
PSA 10
$34
31.0× raw
▬Holdmedium confidence

A model's opinion, not investment advice.

Firebreather

Inferno X · 107 · スーパーレア · 2025

Raw 30d
-2.6%−$0.03
PSA 10 30d
-0.0%−$0.01
PriceCharting monthly level, not sales
PSA 10 gem rate
74.2%
161 of 217 PSA submissions gemmed
Total graded
217
Copies with a published pop report
Raw sales · 30d
7
About 1.7 a week · PriceCharting, annual basis
Price history

What it has been worth

The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.

Firebreather — raw market price
$1.10−90.4% 1Y
$13$6.35$0.00
2025/10/022026/05/122026/06/232026/08/042026/09/30
Raw market price
169 points

Premium2 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock

Graded market

Grade ladder & population report

Every graded price published, next to how many copies exist at that grade.

Raw (ungraded, near mint)
$1.10
30 day
-2.6%

PSA2 grades priced

217 certified in total
GradeMarketvs rawPopulationPop higher
▶PSA 10$34.12
31.0×
1610
▶PSA 9$14.99
13.6×
52161

A model's opinion, not investment advice.